• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:龙冬梅,周茂婷,罗思瑶,李慧娟,彭兴灿,郭楠,王星.龙胆苦苷调控PPAR-γ/Nrf2信号通路改善2型糖尿病小鼠白色脂肪氧化损伤分析[J].药学研究,2026,45(2):141-149[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2821次   下载 869次 本文二维码信息
码上扫一扫!
龙胆苦苷调控PPAR-γ/Nrf2信号通路改善2型糖尿病小鼠白色脂肪氧化损伤分析
龙冬梅1,周茂婷2,罗思瑶2,李慧娟2,彭兴灿2,郭楠3,王星2
字体:加大+|默认|缩小-
(1.南充职业技术学院现代农业技术学院,四川 南充 637131;2.川北医学院药学院,四川 南充 637100;3.复旦大学附属闵行医院药剂科,上海 201199)
摘要:
目的 研究龙胆苦苷(GPS)对2型糖尿病(T2DM)小鼠白色脂肪组织氧化损伤的影响并探讨其作用机制。方法 高脂饮食联合链脲佐菌素(STZ)诱导C57BL/6J小鼠形成T2DM模型后,将其随机分为模型组、GPS低剂量组(25 mg•kg-1)和GPS高剂量组(25 mg•kg-1),另取10只给予正常饲料喂养的C57BL/6J小鼠作为正常对照组,每天灌胃给药1次,持续8周。实验期间测定小鼠基本代谢指标;处死小鼠时留取血清和白色脂肪组织;对白色脂肪组织进行苏木精-伊红(HE)染色;测定小鼠血清中脂质代谢和白色脂肪组织中氧化应激相关指标;Western blot测定白色脂肪组织中过氧化物酶体增殖物激活受体γ(PPAR-γ)和核因子E2相关因子2(Nrf2)蛋白表达。结果,/b> GPS明显降低T2DM小鼠的随机血糖(PBG)、禁食血糖(FBG)、摄食量和饮水量(P<0.01),显著改善T2DM小鼠的口服葡萄糖耐量异常(P<0.01),并提高T2DM小鼠对胰岛素的敏感性(P<0.01);GPS改善T2DM小鼠白色脂肪组织病理形态异常和血脂代谢紊乱(P<0.01),降低白色脂肪重量和白色脂肪指数(P<0.01);GPS显著提高白色脂肪组织中抗氧酶活性和抗氧化物质含量(P<0.01),明显降低丙二醛(MDA)含量(P<0.01);此外,GPS增加白色脂肪组织中蛋白PPAR-γ和Nrf2表达(P<0.01)。结论 GPS可能通过调控PPAR-γ/Nrf2信号通路减轻白色脂肪氧化损伤而发挥其抗T2DM作用。
关键词:  龙胆苦苷  2型糖尿病  白色脂肪组织  氧化应激  过氧化物酶体增殖物激活受体γ/核因子E2相关因子2信号通路
DOI:10.13506/j.cnki.jpr.2026.02.004
基金项目:四川省科技教育联合基金项目(No.2025NSFSC2159);四川省中医药管理局项目(No.25MSZX559);南充市科技计划项目(No.23YYJCYJ0026);川北医学院校级杰出青年项目(No.CBY23-JQ03);川北医学院附属医院科研发展计划项目(No.2023PTZK022)
出版日期:2026-02-25
Study on gentiopicroside regulating the PPAR-γ/Nrf2 signaling pathway to improve oxidative damage in white adipose tissue of the type 2 diabetes mice
LONG Dongmei1,ZHOU Maoting2,LUO Siyao2,LI Huijuan2,PENG Xingcan2,GUO Nan3,WANG Xing2
(1.College of Modern Agricultural Technology, Nanchong Vocational and Technical College, Nanchong 637131, China; 2. Department of Pharmacy, North Sichuan Medical College, Nanchong 637100, China; 3. Department of Pharmacy, Minhang Hospital, Fudan University, Shanghai 201199, China)
Abstract:
Objective To investigate the effect of gentiopicroside (GPS) on oxidative damage in white adipose tissue of type 2 diabetes mellitus (T2DM) mice and explore its underlying mechanism.Methods After a high-fat diet combined with streptozotocin (STZ) induced a T2DM model in C57BL/6J mice, the mice were randomly divided into a model group, a low-dose GPS group (25 mg•kg-1), and a high-dose GPS group (50 mg•kg-1), and another 10 C57BL/6J mice fed with normal diet were taken as the normal control group, and the drug was given orally once a day for 8 weeks. During the experiment, the basic metabolic indices of the mice were measured. When the mice were sacrificed, the serum and white adipose tissue were collected. Pathological staining was performed on the white adipose tissue. Lipid metabolism-related indices in the serum and oxidative stress-related indices in the white adipose tissue were measured. Western blot was used to determine the protein expression of peroxisome proliferator-activated receptor γ (PPAR-γ) and nuclear factor E2-related factor 2 (Nrf2) in the white adipose tissue. Results GPS significantly reduced the postprandial blood glucose (PBG), fasting blood glucose (FBG), food intake, and water intake in T2DM mice (P<0.01). It also significantly improved oral glucose tolerance abnormalities (P<0.01) and enhanced insulin sensitivity in T2DM mice (P<0.01). GPS attenuated the pathological morphological abnormalities in white adipose tissue and lipid metabolism disorders in T2DM mice (P<0.01), and reduced the white fat weight and white fat index (P<0.01). GPS remarkably increased the activity of antioxidant enzymes and the contents of antioxidant substances (P<0.01), and markedly reduced malondialdehyde (MDA) content (P<0.01) in white adipose tissue. Furthermore, GPS increased the expression of PPAR-γ and Nrf2 proteins in white adipose tissue (P<0.01).Conclusions GPS may exert its anti-T2DM effect by alleviating oxidative damage in white adipose tissue through regulating the PPAR-γ/Nrf2 signaling pathway.
Key words:  Gentiopicroside  Type 2 diabetes  White adipose tissue  Oxidative stress  PPAR-γ/Nrf2 signaling pathway
今日访问量:2328    总访问量:55338695
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司